Lars Eckardt

25.8k total citations · 4 hit papers
535 papers, 11.4k citations indexed

About

Lars Eckardt is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Lars Eckardt has authored 535 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 498 papers in Cardiology and Cardiovascular Medicine, 101 papers in Molecular Biology and 55 papers in Surgery. Recurrent topics in Lars Eckardt's work include Cardiac Arrhythmias and Treatments (320 papers), Cardiac electrophysiology and arrhythmias (300 papers) and Atrial Fibrillation Management and Outcomes (203 papers). Lars Eckardt is often cited by papers focused on Cardiac Arrhythmias and Treatments (320 papers), Cardiac electrophysiology and arrhythmias (300 papers) and Atrial Fibrillation Management and Outcomes (203 papers). Lars Eckardt collaborates with scholars based in Germany, Netherlands and Switzerland. Lars Eckardt's co-authors include Günter Breithardt, Gerrit Frommeyer, Wilhelm Haverkamp, Eric Schulze‐Bahr, Peter Milberg, Kristina Wasmer, Paulus Kirchhof, Günter Breithardt, Gerold Mönnig and Dirk G. Dechering and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Lars Eckardt

495 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome

2010 531 citations Vincent Probst, Christian Veltmann et al. Circulation profile →
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial

2010 490 citations Lars Eckardt, Stephan Willems et al. profile →
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

2019 383 citations Lars Eckardt, Andreas Goette et al. profile →
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

2021 141 citations Andreas Rillig, Günter Breithardt et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Eckardt Germany	51	10.4k	3.2k	874	513	499	535	11.4k
Stefan Kääb Germany	47	6.4k 0.6×	3.6k 1.1×	634 0.7×	578 1.1×	442 0.9×	199	8.2k
Wilhelm Haverkamp Germany	49	9.1k 0.9×	3.1k 1.0×	887 1.0×	519 1.0×	734 1.5×	329	11.2k
Martin Borggrefe Germany	49	10.1k 1.0×	4.9k 1.5×	1.3k 1.5×	558 1.1×	1.0k 2.0×	327	12.1k
Anne M. Gillis Canada	44	8.5k 0.8×	1.0k 0.3×	1.1k 1.2×	292 0.6×	590 1.2×	187	9.6k
Fiorenzo Gaïta Italy	58	12.1k 1.2×	2.6k 0.8×	2.2k 2.5×	256 0.5×	1.3k 2.6×	373	14.2k
Pedro Brugada Belgium	72	22.1k 2.1×	8.7k 2.7×	1.5k 1.7×	992 1.9×	931 1.9×	596	23.1k
Warren M. Jackman United States	67	15.6k 1.5×	967 0.3×	1.6k 1.9×	169 0.3×	461 0.9×	221	16.6k
Eric N. Prystowsky United States	60	14.6k 1.4×	1.1k 0.3×	1.7k 1.9×	189 0.4×	843 1.7×	280	15.8k
Philippe Lechat France	42	3.7k 0.4×	806 0.3×	952 1.1×	346 0.7×	413 0.8×	168	7.3k
Andrew Remppis Germany	40	3.9k 0.4×	1.9k 0.6×	872 1.0×	119 0.2×	987 2.0×	102	6.1k

Countries citing papers authored by Lars Eckardt

Since Specialization

Citations

This map shows the geographic impact of Lars Eckardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Eckardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Eckardt more than expected).

Fields of papers citing papers by Lars Eckardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Eckardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Eckardt. The network helps show where Lars Eckardt may publish in the future.

Co-authorship network of co-authors of Lars Eckardt

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Eckardt. A scholar is included among the top collaborators of Lars Eckardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Eckardt. Lars Eckardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goette, Andreas, Marc D. Lemoine, Katrin Borof, et al.. (2025). Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4. EP Europace. 27(10). 1 indexed citations

Plagwitz, Lucas, et al.. (2025). QTcNet: a deep learning model for direct heart rate corrected QT interval estimation. EP Europace. 27(12).

Wolfes, Julian, et al.. (2025). AF-CARE in the Elderly: Implications of the 2024 ESC Guideline on the Management of Atrial Fibrillation in Older Patients. Gerontology. 72(1). 54–62.

Popescu, S S, Alessio Gasperetti, Johannes Brachmann, et al.. (2025). Impact of sex on the utilization of defibrillation-capable cardiac implantable devices and outcome: results from the German device registry. Clinical Research in Cardiology. 115(4). 622–633.

Ellermann, Christian, et al.. (2024). Antiarrhythmic Treatment in Heart Failure. Current Heart Failure Reports. 21(1). 22–32. 3 indexed citations

Wolfes, Julian, Gerrit Kaleschke, Julia Vormbrock, et al.. (2024). Pacemaker Implantation for Low‐Grade Conduction Abnormalities After Balloon‐Expandable Transcatheter Aortic Valve Implantation. Clinical Cardiology. 47(11). e70028–e70028.

Kaess, Bernhard M., Christian Ruckes, Christian Meyer, et al.. (2024). Pulmonary Vein Isolation or Pace and Ablate in Elderly Patients With Persistent Atrial Fibrillation (ABLATE Versus PACE)—Rationale, Methods, and Design. Canadian Journal of Cardiology. 40(12). 2429–2440. 5 indexed citations

Bietenbeck, Michael, Michael Schäfers, Michael Möhr, et al.. (2024). Cardiac Sarcoidosis—Diagnostic and Therapeutic Challenges. Journal of Clinical Medicine. 13(6). 1694–1694. 4 indexed citations

Wolfes, Julian, et al.. (2023). Catheter Ablation of Ventricular Tachycardia in the Presence of Mechanical Aortic and Mitral Valve Replacement. JACC. Clinical electrophysiology. 10(2). 429–438. 2 indexed citations

10.

Leitz, Patrick, Gerrit Frommeyer, Martin Ritter, et al.. (2023). Predictors of Atrial Fibrillation in Patients with Embolic Stroke of Unknown Etiology and Implantable Loop Recorders—Further Insights of the TRACK AF Study on the Role of ECG and Echocardiography. Journal of Clinical Medicine. 12(20). 6566–6566. 1 indexed citations

11.

Rath, Benjamin, Kevin Willy, Christian Ellermann, et al.. (2023). Ventricular arrhythmia burden in ICD patients during the second wave of the COVID-19 pandemic. Clinical Research in Cardiology. 113(10). 1463–1468. 2 indexed citations

12.

Leitz, Patrick, Kristina Wasmer, Christian Andresen, et al.. (2022). The Incidence, Electrophysiological Characteristics and Ablation Outcome of Left Atrial Tachycardias after Pulmonary Vein Isolation Using Three Different Ablation Technologies. Journal of Cardiovascular Development and Disease. 9(2). 50–50. 1 indexed citations

13.

Ellermann, Christian, Julian Wolfes, Benjamin Rath, et al.. (2022). Electrophysiologic effects of sacubitril in different arrhythmia models. European Journal of Pharmacology. 917. 174747–174747. 2 indexed citations

14.

Plagwitz, Lucas, Benjamin Rath, Gerrit Frommeyer, et al.. (2022). Detection of Patients with Congenital and Often Concealed Long-QT Syndrome by Novel Deep Learning Models. Journal of Personalized Medicine. 12(7). 1135–1135. 12 indexed citations

15.

Wegner, Felix K., Nils Bögeholz, Patrick Leitz, et al.. (2017). Occurrence of primarily noninducible atrioventricular nodal reentry tachycardia after radiofrequency delivery in the slow pathway region during empirical slow pathway modulation. Clinical Cardiology. 40(11). 1112–1115. 2 indexed citations

16.

Steven, Daniel, Hendrik Bonnemeier, Thomas Deneke, et al.. (2015). Diagnostik bei supraventrikulären Tachykardien. Herzschrittmachertherapie + Elektrophysiologie. 26(2). 167–172. 4 indexed citations

17.

Schlüter, Michael, Christian Butter, Julia Köbe, et al.. (2012). Shock Efficacy of Subcutaneous Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death. Circulation Arrhythmia and Electrophysiology. 5(5). 913–919. 62 indexed citations

18.

Frommeyer, Gerrit, Sven Kaese, Jörg Stypmann, et al.. (2012). Further Insights into the Underlying Electrophysiological Mechanisms for Reduction of Atrial Fibrillation by Ranolazine in an Experimental Model of Chronic Heart Failure. European Journal of Heart Failure. 14(12). 1322–1331. 41 indexed citations

19.

Probst, Vincent, Christian Veltmann, Lars Eckardt, et al.. (2010). Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome. Circulation. 121(5). 635–643. 531 indexed citations breakdown →

20.

Eckardt, Lars, et al.. (2010). European Perspectives. Circulation. 122(17). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact